Effects of bradykinin and icatibant on renal hemodynamics in conscious spontaneously hypertensive and normotensive rats

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 4, 1997, Pages 446-454

  Braun, Claude ^a,b   Ade, Manuela ^a   Unger, Thomas ^a   Van Der Woude, Fokko J ^a   Rohmeiss, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Bradykinin; Icatibant; Kidney; Renal blood flow; Spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ESSENTIAL HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BRADYKININ; HEMODYNAMIC PROCESSES; KIDNEY; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, VASOPRESSIN; SPECIES SPECIFICITY;

EID: 0030707616     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199710000-00007     Document Type: Article

References (44)

1. Carretero OA, Scicli AG. Kinins, paracrine hormones in the regulation of blood flow, renal function and blood pressure. In: Laragh JH, Brenner BM, Kaplan NM, eds. Endocrine mechanisms in hypertension. New York: Raven Press, 1989:219-39.
2. Levinky NG. The renal kalllikrein-kinin system. Circ Res 1979; 44:441-1.
3. Carretero OA, Carbini LA, Scicli AG. The molecular biology of the kallikrein-kinin system: general description, nomenclature and the mouse gene family. J Hypertens 1993;11:693-7.
4. Cherry PD, Furchgott RF, Zawadzki JV, Jothianandan LM. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982;79:2106-10.
5. Regoli D, Rhaleb NE, Drapeau G, Dion DS. Kinin receptor subtypes. J Cardiovasc Pliannacol 1990;15(suppl 6):30-8.
6. 1 type and their antagonists. In: Burch RM, éd. Bradykinin antagonists: basic and clinical research. New York: Marcel Decker, 1988:37-78.
7. 2bradykinin receptor in rat renal mesangial cells. Eur J Pharmacol 1990;190:381-92.
8. Manning DC, Snyder SH. Bradykinin receptors localized by quantitative autoradiography in kidney, ureter and bladder. Am J Physiol 1989;256:F909-15.
9. Beierwaltes WH, Carretero OA, Scicli AG. Renal hemodynamic response to a kinin analogue antagonist. Am J Physiol 1988;255:F408-14.
10. Flamenbaum W, Gagnon J, Ramwell P. Bradykinin induced renal hemodynamic alterations: renin and prostaglandin relationships. Am J Physiol 1979;237:F433-40.
11. Mattson DL, Cowley AW. Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 1993;21:961-5.
12. Roman RJ, Kaldunski ML, Scicli AG, Carretero OA. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am J Physiol 1988;255:F690-8.
13. Smits JFM, Brody MJ. Activation of afferent renal nerves by intrarenal bradykinin in conscious rats. Am J Physiol 1984;247:R1003-8.
14. Day T, Ciriello J. Effects of renal receptor activation on neurosecretory vasopressin cells. Am J Physiol 1987;253:R234-41.
15. Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 1989;67:858-64.
16. Walker LA, Buscemi-Bergin M, Gellai M. Renal hemodynamics in conscious rats: effects of anesthesia, surgery, and recovery. Am J Physiol 1983;245:F67-74.
17. Cachofeiro V, Nasjletti A. Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Hypertension 1991;18:983-8.
18. Stier CT, Selig N, Itskovitz HD. Enhanced renal vasodilatory responses to bradykinin in stroke-prone spontaneously hypertensive rats [Abstract]. Clin Res 1989;37:502A.
19. Thomas GR, Walder CE, Thiemermann C, Vane Regional vascular resistance and renal hemodynamics in the spontaneously hypertensive rat: the effects of bradykinin. J Cardiovasc Pharmacol 1990;15:211-7.
20. Sharma JN. Do kinins mediate the hypertensive actions of angiotensin converting enzyme (ACE) inhibitors? Gen Pharmacol 1990;21:451-7.
21. Bathon JMN, Proud D. Bradykinin antagonists. Annu Rev Pharmacol Toxicol 1991 ;31:129-62.
22. Mulinari A, Benetos A, Gavras I, Gavras H. Interaction of bradykinin with catecholamines in blood pressure regulation. Hypertension 1987; 10:374-7.
23. Rhaleb NE, Telemaque S, Rouissi N, et al. Structure-activity studies of bradykinin and related peptides: B2-receptor antagonist. Hypertension 1991:17:107-15.
24. Breipohl G, Henke S, Knolle J, Anagnostopoulos H, Schölkens BA. Hoe 140: a new and highly potent bradykinin antagonist Communication presented to the Symposium: Peptidergic receptors and peptide processing as therapeutic target. Nice, France, April 8-11, 1990.
25. Hock FJ, Wirth K, Albus U, et al. Hoe 140: a new potent and long acting bradykinin antagonist: in vitro studies. Br J Pharmacol 1990; 102:769-73.
26. Lembeck F, Griesbacher T, Eckhardt M, Henke S, Breipohl G, Knolle J. New, long-acting, potent bradykinin antagonists. Br J Pharmacol 1991;102:297-304.
27. Bao G, Quadri F, Stauss B, Stauss H, Gohlke P, Unger TH. Hoe 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur J Pharmacol 1991:200:179-82.
28. 2-receptor antagonist, on renal function in conscious normotensive rats. Br J Pharmacol 1992;106:380-6.
29. Parekh N. A novel method for infusing continuously into the renal artery of rats. Am J Physiol 1995;268:F967-71.
30. Braun C, Lüdicke C, Rebsch W, Gretz N, van der Woude FJ, Rohmeiss P. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats. Nephrol Dial Transplant 1996; 11 (suppl 6):52-7.
31. Wende P, Strauch M, Unger TH, Gretz N, Rohmeiss P. Autoregulation of renal blood flow, glomerular filtration rate and plasma renin activity in spontaneously hypertensive rats and normotensive Wistar rats. Med Klin 1993;88(4}:207-11.
32. Drost C. Vessel-diameter independent volume flow measurements using ultrasound. Proc San Diego Biomed Symp 1978;17:299-302.
33. SAS Institute. SAS user's guide: statistics. Cary, NC: SAS Institute, 1985.
34. Ignarro LJ, Edwards JC, Gruetter DY, Barry BK, Crueller CA. Possible involvement of S-nilrothiols in the activalion of guanylale cyclase by nitroso compounds. FEBS Lett 1980; 110:275-8.
35. Moncada S, Radomski M\V, Palmer RMJ. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-501.
36. Weaver LC, Genovesi S, Stella A, Zanchetti A. Neural, hemodynamic, and renal responses to stimulation of intestinal receptors. Am J Physiol 1987;253:H1167-76.
37. Zimpfer M, Sit SP, Vatner SF. Effects of anesthesia on the canine carotid chemoreceptor reflex. Circ Res 1981;48:400-6.
38. Cox RH, Bagshaw FJ. Influence of anesthesia on the response to carotid hypotension in the dog. Am J Physiol 1979;237:H424-32.
39. Dibona GF. The function of the renal nerves. Rev Physiol Biochem Pharmacol 1982;94:76-81.
40. 1-adrenoceptors. Pflugers Arch 1990;417:42-7.
41. Van der Kamp KWHJ, van Oeveren W. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials. J Biomed Mater Res 1994;28:349-52.
42. Van der Kamp KWHJ, Hauch KD, Feijen J, Horbett TA. Contact activation during incubation of five different polyurethanes or glass in plasma. J Biomed Mater Res 1995;29:1303-6.
43. Mindroiu T, Carretero OA, Scicli AG. T-Kininogen in rat plasma after nephrectomy and other surgical traumas. In: Carretero OA, ed. Vasodepressor hormones. Basel: Birkhäuser Verlag, 1987:265-76.
44. Saugstad ÖD, Aasen AO, Guldvog I, Lium B, Lyngaas K, Amundsen E. Changes of components of the plasma kallikrein-kinin system during experimental lung insufficiency in dogs. Acta Chir Scand 1982;(suppl 509):61-7.